|
CAST expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.214300E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.025900E-02 |
| Normal-vs-Stage2 |
2.624000E-01 |
| Normal-vs-Stage3 |
4.878600E-01 |
| Normal-vs-Stage4 |
2.643600E-01 |
| Stage1-vs-Stage2 |
8.459200E-01 |
| Stage1-vs-Stage3 |
1.701600E-01 |
| Stage1-vs-Stage4 |
7.322200E-01 |
| Stage2-vs-Stage3 |
5.109800E-01 |
| Stage2-vs-Stage4 |
9.175600E-01 |
| Stage3-vs-Stage4 |
5.496200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.048400E-02 |
| Normal-vs-AfricanAmerican |
7.260400E-01 |
| Normal-vs-Asian |
8.558200E-02 |
| Caucasian-vs-AfricanAmerican |
3.873400E-01 |
| Caucasian-vs-Asian |
4.214800E-01 |
| AfricanAmerican-vs-Asian |
2.892200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.060220E-01 |
| Normal-vs-Female |
7.526300E-02 |
| Male-vs-Female |
5.677600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.368200E-01 |
| Normal-vs-Age(41-60Yrs) |
8.907600E-02 |
| Normal-vs-Age(61-80Yrs) |
6.587800E-02 |
| Normal-vs-Age(81-100Yrs) |
9.374800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.117200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.239600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.116400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.392000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.523200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.904000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
7.069400E-01 |
| Normal-vs-Grade 2 |
6.061100E-03 |
| Normal-vs-Grade 3 |
3.466600E-01 |
| Normal-vs-Grade 4 |
7.544400E-01 |
| Grade 1-vs-Grade 2 |
1.747160E-01 |
| Grade 1-vs-Grade 3 |
8.571600E-01 |
| Grade 1-vs-Grade 4 |
8.549400E-01 |
| Grade 2-vs-Grade 3 |
5.080500E-02 |
| Grade 2-vs-Grade 4 |
5.411600E-02 |
| Grade 3-vs-Grade 4 |
6.465600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
6.283400E-03 |
| Normal-vs-ccB subtype |
1.368840E-01 |
| ccA subtype-vs-ccB subtype |
2.180200E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.054100E-02 |
| Normal-vs-N1 |
5.561400E-01 |
| N0-vs-N1 |
2.390200E-01 |
|
|
